C3 and neoplasm: Supporting this notion, several studies have shown that complement components such as C3a and C5a mediate tumor-promoting responses by modulating immune cell functions, recruiting MDSCs, and shifting immune responses toward immunosuppressive T-helper-2 (TH2) cells and regulatory T-cells (Tregs).